Flagship Harbor Advisors, LLC Sarepta Therapeutics, Inc. Transaction History

Flagship Harbor Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$125.56 - $178.74 $19,587 - $27,883	-156 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$93.0 - $171.7 $4,185 - $7,726	45 Added 40.54%	156 $25,000
Q3 2019 Oct 22, 2019	SELL	$72.81 - $156.91 $3,276 - $7,060	-45 Reduced 28.85%	111 $8,000
Q2 2019 Jul 22, 2019	BUY	$112.21 - $151.95 $3,366 - $4,558	30 Added 23.81%	156 $23,000
Q1 2019 Apr 15, 2019	SELL	$106.67 - $151.68 $5,333 - $7,584	-50 Reduced 28.41%	126 $15,000
Q3 2018 Nov 05, 2018	SELL	$115.31 - $161.51 $4,035 - $5,652	-35 Reduced 16.59%	176 $26,000
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $15,137 - $32,428	211 New	211 $27,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.